Menu Search
Equities

Frontier Biotechnologies Inc

688221:SHH

Frontier Biotechnologies Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.43
  • Today's Change-0.09 / -1.20%
  • Shares traded5.47m
  • 1 Year change-33.36%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast in CNY

The one analyst offering a 12 month price target expects Frontier Biotechnologies Inc share price to rise to 15.80 in the next year from the last price of 7.43.
High112.7%15.80
Med112.7%15.80
Low112.7%15.80

Earnings history & estimates in CNY

On Feb 27, 2023, losses of -0.35 per share. This result was in line with the expectation of the one analyst following the company
The next earnings announcement is expected on Feb 27, 2025.
Average growth rate-14.22%
Frontier Biotechnologies Inc reported annual 2023 losses of -0.88 per share on Feb 23, 2024.
Average growth rate-5.30%
More ▼

Revenue history & estimates in CNY

of 27.08m. This missed the 41.22m estimate of the one analyst following the company.
Average growth rate+81.48%
Frontier Biotechnologies Inc had revenues for the full year 2023 of 114.25m. This was 34.82% above the prior year's results.
Average growth rate+43.64%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.